Search Results - "Deryusheva, I. V."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Human papillomavirus and lung cancer: an overview and a meta-analysis by Tsyganov, M. M., Pevzner, A. M., Ibragimova, M. K., Deryusheva, I. V., Litviakov, N. V.

    “…Purpose This review is devoted to assessing the prevalence of human papillomavirus (HPV) in lung cancer (LC) in the world. HPV is recognized as the etiological…”
    Get full text
    Journal Article
  2. 2

    Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients by Deryusheva, I V, Tsyganov, M, Garbukov, E Y, Ibragimova, M K, Kzhyshkovska, Ju G, Slonimskaya, E, Cherdyntseva, N V, Litviakov, N V

    Published in Experimental oncology (01-07-2017)
    “…One of the factors providing the diversity and heterogeneity of malignant tumors, particularly breast cancer, are genetic variations, due to gene polymorphism,…”
    Get more information
    Journal Article
  3. 3

    A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY by Efteev, L. A., Rodionov, E. O., Miller, S. V., Tuzikov, S. A., Tsyganov, M. M., Deryusheva, I. V., Litvyakov, N. V., Frolova, I. G.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-11-2019)
    “…Despite advances in the treatment of non-small cell lung cancer (NSC LC), prognosis of advanced lung cancer is extremely poor. The search for additional…”
    Get full text
    Journal Article
  4. 4

    RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR by Tsyganov, M. M., Tarabanovskaya, N. A., Deryusheva, I. V., Ibragimova, M. K., Kazantseva, P. V., Pevzner, A. M., Slonimskaya, E. M., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (30-06-2019)
    “…Currently, the presence of the germinal mutation BRCA1 5382insC in breast cancer patients is one of the determining factors for prescribing platinum-based…”
    Get full text
    Journal Article
  5. 5

    mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer by Tsyganov, M. M., Deryusheva, I. V., Rodionov, E. O., Efteev, L. A., Miller, S. V., Ibragimova, M. K., Perminova, E. E., Cheremisina, O. V., Frolova, I. G., Tuzikov, S. A., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (28-02-2019)
    “…The objective response rate to neoadjuvant chemotherapy (NAC) in patients with non-small cell lung cancer (NSCLC) is approximately 16 %. Therefore, the search…”
    Get full text
    Journal Article
  6. 6

    Physical status of human papillomavirus in the prognosis of recurrence of low-grade and-high-grade cervical intraepithelial lesions by Ibragimova, M. K., Churuksaeva, O. N., Bychkov, V. A., Tsyganov, M. M., Deryusheva, I. V., Shpileva, O. V., Kolomiets, L. A., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-01-2019)
    “…The study included 168 patients with precancerous cervical lesions 37 with low-grade squamous intraepithelial lesions (LSIL), 131 with high-grade squamous…”
    Get full text
    Journal Article
  7. 7

    The clinical observation of human papillomavirus positive breast tumor by Ibragimova, M. K., Tsyganov, M. M., Tarabanovskaya, N. A., Tashireva, L. A., Deryusheva, I. V., Perelmuter, V. M., Slonimskaya, E. M., Litviakov, N. V.

    Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (30-03-2018)
    “…In this manuscript, a unique case of HPV16-positive breast cancer is examined. The presence of HPV infection in the tumor is confirmed by two independent…”
    Get full text
    Journal Article
  8. 8

    BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer by Tsyganov, M. M., Ibragimova, M. K., Deryusheva, I. V., Kazantseva, P. V., Garbukov, E. Yu, Slonimskaya, E. M., Litviakov, N. V.

    Published in Uspehi molekulârnoj onkologii (14-05-2018)
    “…Background. Most modern studies are limited to the study of only germline mutations of the BRCA1 gene (most often 5382insC). And there are very few works that…”
    Get full text
    Journal Article
  9. 9

    EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION by Litviakov, N. V., Tsyganov, M. M., Ibragimova, M. K., Deryusheva, I. V., Kazantseva, P. V., Mitrofanova, I. V., Frolova, I. G., Buldakov, M. A., Slonimskaya, E. M., Choinzonov, E. L., Kzhyshkovska, Yu. G., Cherdyntseva, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-12-2017)
    “…Background. Tumor-associated macrophages (TAM) are the main innate immunity cells that regulate the relationship between the infiltrating immunocompetent…”
    Get full text
    Journal Article
  10. 10

    Phenomenon of loss of heterozygosity in tumour tissue of breast cancer: association with expression of monoresistance genes by Tsyganov, M. M., Deryusheva, I. V., Garbukov, E. Yu, Ibragimova, M. K., Kazantseva, P. V., Bychkov, V. A., Slonimskaya, E. M., Litviakov, N. V.

    Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (01-01-2017)
    “…Purpose of work. To perform a genome-wide association study of loss of heterozygosity (LOH) with monoresistance genes expression during neoadjuvant…”
    Get full text
    Journal Article